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Abstract
Background: The role of inflammation in the pathogenesis and progression of atherosclerosis has been
increasingly discussed. Although the seroepidemiological studies have suggested a relationship between
Helicobacter pylori (H. pylori) infection and atherosclerosis; the issue is still controversial. It is well known that
abnormal lipid profil is related to atherosclerosis and the measurement of carotid-intima media thickness (CIMT) is
one of the surrogate marker of atherosclerosis. The serum concentration of high-density lipoprotein (HDL-C) has
been known to have an inverse correlation with the development of atherosclerosis. Paraoxonase-1 (PON1) is a
major anti-atherosclerotic component of HDL-C. PON1 activity is related to lipid peroxidation and prospective
cardiovascular risk. The aim of this study was to investigate CIMT and serum PON1 activities along with lipid
parameters in H. pylori positive and negative subjects.
Methods: Thirty H. pylori positive subjects and thirty-one negative subjects were enrolled. H. pylori infection was
diagnosed by the presence of positivity of stool H. pylori antigen test or Carbon 14 labeled urea breath test. Serum
PON1 activity was measured spectrophotometrically. Traditional cardiovascular risk factors were investigated and
laboratory analysis included measurement of serum triglycerides (TG), total cholesterol (TC), high-density lipoprotein
(HDL-C) and low-density lipoprotein cholesterol (LDL-C). We assessed CIMT by high-resolution ultrasound of both
common carotid arteries.
Results: We found that the mean and maximum values of right and overall CIMT in H. pylori positive subjects were
significantly thicker than those of H. pylori negative subjects. There was no significant differences in serum HDL-C,
LDL-C, TC levels and TC/HDL-C ratios between two groups. Serum TG levels of H. pylori positive subjects were
significantly higher than those of H. pylori negative subjects (p = 0.014). We found that PON1 activities were
significantly lower in H. pylori positive subjects compared with negative subjects. No significantly correlation was
observed between PON1 and CIMT values.
Conclusions: There is an increase in CIMT values in patients with H. pylori positive compared to H. pylori negative
subjects. PON1 activity decrease significantly in H. pylori positive subjects. However, an association between PON1
and CIMT was not found. These data indicated that H. pylori may have a role in atherosclerotic processes, however,
further studies are needed to evaluate the exact mechanisms.
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Introduction
Helicobacter pylori is a gram negative curved bacillus
that is frequently found in the human stomach and
causes chronic and active gastritis, peptic ulcer disease
and is associated with gastric adenocarcinoma [1,2]. Sev-
eral studies have demonstrated that H. pylori infection is
also associated with the development of coronary ather-
osclerosis [3]. Atherosclerosis pathogenesis includes
abnormal lipid metabolism, endothelial dysfunction,
inflammatory and immunological factors, plaque rupture
and smoking [4]. Infectious processes can contribute to
the pathogenesis of atherosclerosis by producing chronic
infection of the vessels with inflammation leading to
endothelial dysfunction [5]. It has been suggested that
exposure to sustained high levels of endotoxin constitute
a risk factor for atherosclerosis in animal models and,
likely, in humans [5,6].
A low concentration of HDL-C is a well-known risk
factor for coronary heart disease [5]. There are several
well-documented functions of high plasma levels of
HDL-C preventing the development of atherosclerosis.
Most important function of HDL is to promote the
efflux of cholesterol from cells. HDL-C also possesses
antioxidant and antiinflammatory activities. The antioxi-
dant activity of HDL-C is largely due to its paraoxo-
nase-1 (PON1) content [7]. Human serum paraoxonase
(PON1), a high-density lipoprotein (HDL)-bound ester
hydrolase enzyme, has been shown to protect LDL from
in vitro oxidation by hydrolysis of biologically active
lipoperoxides [4]. Animal studies, including PON1-
knockout mouse, demonstrated that PON1 deficiency
was shown to increase susceptibility to LDL oxidation
and atherosclerosis development [8]. In humans, it has
been suggested that PON1 is significantly associated
with atherosclerotic risk. PON1 activity is geneticly
regulated and varies widely among populations [9]. Pre-
vious studies have shown LDL oxidation and the degra-
dation of PON1 activity were significantly correlated
[10]. Although serum PON1 activity in patients with
coronary heart disease is decrease and is negatively
related to the severity of coronary artery lesions, the
correlation between PON1 activity and CIMT is contro-
versial [11,12].
Existing cardiovascular diseases (CVDs) are found to
be correlated with carotid artery intima-media thickness
(CIMT) measured by ultrasound and are predictive of
CVD in individuals without clinically evident disease.
CIMT is now widely used as a early marker for athero-
sclerotic disease [13].
The aim of the present study was to evaluate the asso-
ciation between serum PON-1 activities and CIMT
values in patients with H. pylori. For this purpose, we
measured the CIMT and we compared the serum PON-




This study was approved by institutional ethical commit-
tee of Akdeniz University, Faculty of Medicine. The sub-
jects were selected among adults who visited the
Department of Gastroenterology because of dyspeptic
symptoms and were tested for H. pylori infection in
Akdeniz University Hospital, between August and
November 2009. H. pylori infection was identified by the
presence of positivity of H. pylori stool antigen test or
Carbon 14 labeled urea breath test. We excluded patients
who had acute infectious, rheumatologic and cardiovas-
cular disease. For the study we included 30 H. pylori
infected individuals (14 male and 16 female). 31 healthy
noninfected, (15 male and 16 female), age and sex
matched individuals were enrolled in this study for a con-
trol. All subjects were informed about the study and the
written consent was obtained. We obtained detailed med-
ical history about smoking habits, the presence of dia-
betes mellitus, hypertension, hyperlipidemia, family
history of cardiovascular.disease and medication includ-
ing antihypertensive and antihyperlipidemic drugs. Blood
pressure was measured with manual sphygmoman-
ometer. Body mass index (BMI; kg/m2) was calculated by
dividing the body weight (kg) with squared height (m2).
Their routine laboratory tests which contain complete
blood count, serum glucose, creatinine and alanin amino-
transferase (ALT) levels were recorded.
Measurement of Serum Lipid and Lipoprotein Levels
Venous blood samples were obtained following an over-
night fasting state. Serum samples were separated and
stored at -80°C until the analysis. Serum total choles-
terol (TC), HDL cholesterol (HDL-C) and triglyceride
(TG) levels were measured with the enzymatic colori-
metric method by using commercial kits on a Modular
PPP auto-analyzer (Roche Diagnostics). Serum LDL-C
levels were calculated by using Friedewald formula [14].
Serum TC/HDL-C ratio was also calculated. This ratio
represents an atherogenic index, which is an important
prognostic marker for cardiovascular disease [15].
Measurement of Serum PON1 Activity
Serum PON1 activity was measured by adding serum to
Tris buffer (100 mmol/L, pH 8.0) containing 2 mmol/L
CaCl2 and 5.5 mmol/L paraoxon (O, O-diethyl-O-
p-nitrophenylphosphate; Sigma Chemical Co). The rate
of generation of p-nitrophenol was determined at 405 nm.
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according to MacKness B et al. [16]. The method was
applied to an automated analyzer (Syva V-Twin,
Siemens Diagnostics). The results are expressed as U/L.
Ultrasound Scanning Procedure
Subjects were evaluated for carotid intima media thick-
ness (CIMT) and plaque occurrence by using high reso-
lution grey-scale Doppler ultrasonography. In a semi-
dark room, all subject lay supine with their necks
slightly hyperextended and rotated away from the ima-
ging transducer. Both carotid arteries were scanned.
CIMT was defined as the distance between the leading
edge of the lumen intimal interface and the leading edge
of the media adventitia interface of the far wall [13].
Statistical Analysis
Data analysis was done with a statistical software pack-
age (SPSS for Windows, Version 16.0, SPSS Inc, and
Chicago, Ill). Quantitative data were expressed as mean
(± SD) or as medians. The comparisons of parameters
were performed using Student’s t-test. Correlation ana-
lyses were performed using Pearson’s correlation test.
A p-value of < 0.05 was considered as significant.
Results
We included 30 subjects (14 male, 16 female) infected
with H. pylori and 31 subjects (15 male, 16 female)
without H. pylori infection. The demographic and clini-
cal characteristics of study population are shown in
Table 1. There were no statistically significant differ-
ences between two groups with regard to demographic
and clinical characteristics (age, gender, BMI, smoking
habits; history of diabetes mellitus; hypertension; family
history for CVD).
As shown in Table 2; serum TG levels were signifi-
cantly higher in H. pylori positive subjects than H. pylori
negative subjects (1.81 ± 0.79 mmol/L vs 1.32 ± 0.73
mmol/L, p < 0.05). There were no statistically significant
differences in TC, HDL-C, LDL-C levels and TC/HDL-C
ratios between the two groups. Serum PON1 activity
was significantly lower in H. pylori positive subjects
when compared with negative subjects (270.03 ± 84.82
vs 340.00 ± 123.70 U/L, p < 0.05).
Structural measurements of vessels for H. pylori posi-
tive and negative subjects at enrollment are shown in
Table 3. Atherosclerotic plaques in the common carotid
artery were shown in 1% (3 of 30) of H. pylori positive
patients and only 0.3% (1 of 30) of control subjects. The
mean and maximum values of right CIMT were signifi-
cantly increased in H. pylori positive subjects compared
with negative subjects (p < 0.05). The mean and maxi-
mum values of left CIMT were tend to be higher in sub-
jects with H. pylori but the differences were not
statistically significant between two groups. We calcu-
lated mean and maximum overall CIMT by using left
and right CIMT measurements. The mean and maxi-
mum values of overall CIMT were significantly higher
in H. pylori positive subjects than negative subjects (p <
0.05) (Table 3).
In H. pylori positive subjects, serum PON1 activities
were significantly correlated with HDL-C (r = 0.732, p <
0.05), with TG (r = -0.689, p < 0.05) and TC/HDL-C
ratio (r = -0.334, p < 0.05). Serum HDL-C levels were
significantly correlated with mean (r = -0.348, p < 0.05)
and maximum (r = -0.366, p < 0.05) right CIMT, mean
(r = -0.403, p < 0.05) and maximum (r = -0.403, p <
0.05) overall CIMT values while no correlation was
found with mean and maximum left CIMT values (p >
0.05). We did not found any significant correlation
between PON1 and CIMT values.
In H. pylori negative subjects, serum PON1 activities
were significantly correlated with TG (r = -0.398,
Table 1 Demographic and Clinical Characteristics of Helicobacter pylori positive and negative subjects
Parameter H. pylori positive subjects
(n = 30)
H. pylori negative subjects
(n = 31)
p value
Age (years) 40.9 ± 10.3 42.3 ± 9.4 NS
Gender M/F 13/17 14/16 NS
DM 1 2 NS
HT 4 4 NS
HPL 8 10 NS
Smoking 12 15 NS
Family history of CVD 3 4 NS
Systolic BP (mmHg) 119 ± 3 121 ± 8 NS
Diastolic BP (mmHg) 78.5 ± 8.8 79 ± 6.6 NS
BMI (kg/m2) 27.1 ± 3.7 26.2 ± 3.8 NS
Results are expressed as mean ± SD or number of patients.
Abbreviations: DM: diabetes mellitus, HT: hypertension, HPL: hyperlipidemia, CVD: cardiovascular disease, Systolic BP: systolic blood pressure, Diastolic BP:
diastolic blood pressure. BMI: body mass index, NS: non-significant
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p < 0.05), HDL-C (r = 0.938, p < 0.05) and TC/HDL-C
ratio (r = -0.628, p < 0.05). We did not find any signifi-
cant correlation between serum PON1 activities and
CIMT values (all p > 0.05).
Discussion
A relation between atherosclerosis and chronic H. pylori
infection was found in epidemiological studies [17-19].
Pellicano et al. reported significantly higher prevalence
of H. pylori infection in patients with CAD than in con-
trols (77% vs 59%) [20]. Although these studies have
suggested a relationship between H. pylori infection and
coronary heart disease; some of the underlying mechan-
isms still need to be discovered. It has been reported
that chronic H. pylori infection results in decreased
HDL-C levels, and these lipid alterations could, partially
contribute to the initiation and development of coronary
atherosclerosis [5,21,22]. Infection and inflammation are
associated with a decrease in HDL-C levels. Induction of
changes in lipoproteins by cytokines indirectly
predisposes patients to atherosclerosis [23]. In the pre-
sent study, we did not find any significant difference in
TC, HDL-C, LDL-C levels and TC/HDL-C ratios
between H. pylori positive and negative subjects. How-
ever, H. pylori positive subjects had significantly higher
plasma triglyceride levels than negative subjects. Laurila
et al. found significantly increased triglyceride (1.17 vs
1.00 mmol/L) and total cholesterol (6.34 vs 5.87 mmol/
L) levels in 460 H. pylori positive subjects compared
with 269 H. pylori negative subjects but HDL-C levels
were found to be similar in both groups [24].
Major risk factors of atherosclerosis may explain only
50% of its etiology. Therefore, looking for new risk fac-
tors of atherosclerosis is necessary. HDL-C is a well
known parameter inversely related to the risk for CVD.
It plays a key role in the reverse cholesterol transport,
protects LDL against oxidation and reduces lipoprotein
associated peroxides. The antioxidant characteristics of
HDL-C have been attributed to PON 1. In recent years,
authors have suggested that low PON1 activity and
Table 2 Biochemical variables in Helicobacter pylori positive and negative subjects
Parameter H. pylori positive subjects
(n = 30)
H. pylori negative subjects
(n = 31)
p value
Hb (g/dL) 13.6 ± 1.8 13.8 ± 1.5 NS
WBC (×10’/L) 7.38 ± 1.45 7.56 ± 1.98 NS
Glu (mmol/L) 5.44 ± 2.14 4.95 ± 0.67 NS
ALT (U/L) 28.4 ± 21 25.6 ± 23 NS
TC (mmol/L) 4.47 ± 1.32 4.69 ± 0.98 NS
LDL-C (mmol/L) 2.74 ± 0.80 2.84 ± 0.77 NS
HDL-C (mmol/L) 1.15 ± 0.30 1.21 ± 0.38 NS
TG (mmol/L) 1.81 ± 0.79 1.32 ± 0.73* < 0.05
Cr (μmol/L) 63.64 ± 13.26 68.06 ± 9.72 NS
TC/HDL-C 4.13 ± 1.65 4.27 ± 1.95 NS
PON1 (U/L) 270.03 ± 84.82 340.00 ± 123.70* < 0.05
Abbreviations: Hb: Hemoglobin, WBC: White blood cell, Glu: Glucose, ALT, Alanin amino transferase, TC: Total cholesterol, LDL-C: Low density lipoprotein-
cholesterol, HDL-C: High density lipoprotein- cholesterol, TG: triglyceride, Cr: Creatinine, TC/HDL-C: Total cholesterol/HDL cholesterol, PON1: paraoxonase-1, NS:
non-significant.
Results are expressed as mean ± SD. * p < 0.05 statistically significant
Table 3 Structural and functional parameters of vessels for Helicobacter pylori positive and negative subjects
Parameter H. pylori positive subjects
(n = 30)
H. pylori negative subjects
(n = 31)
p value
Mean Right CIMT (mm) 0.70 ± 0.09 0.64 ± 0.06 < 0.05
Max Right CIMT (mm) 0,81 ± 0,10 0.74 ± 0.07 < 0.05
Mean Left CIMT (mm) 0.72 ± 0.14 0.67 ± 0.08 NS
Max Left CIMT (mm) 0.83 ± 0.15 0.79 ± 0.1 NS
Mean Overall CIMT (mm) 0.71 ± 0.10 0.65 ± 0.06 < 0.05
Max Overall CIMT (mm) 0.82 ± 0.11 0.77 ± 0.01 < 0.05
Plaque 3 1
Abbreviations: CIMT: Carotis intima-media thickness, NS: non-significant Results are expressed as mean ± SD or number of patients
* p < 0.05 statistically significant
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concentration were important determinants of the pre-
sence of coronary artery disease [25]. Several factors like
nutritional, pharmacological, genetic and infectious pro-
cesses have been demonstrated to modulate PON1
levels [9]. Relationship between PON1 activity and infec-
tious pathogens like HCV and HIV have been shown
[26,27]. But, association between H. pylori infection and
PON1 has been reported in only one study [4]. Aslan et
al. found decreased serum PON1 activity in H. pylori
positive patients [4]. In our study we also observed that
serum PON1 activity was significantly lower in H. pylori
positive subjects when compared with negative subjects.
There is considerable evidence suggesting that ultraso-
nic measurements of early atherosclerosis are clinically
significant. In prospective studies increased IMT has
been related to an increased risk of cardiovascular dis-
eases [28,29]. There is conflicting data regarding CIMT
and H. pylori infection. Some researchers have reported
no relationship between H. pylori and CIMT [23,30,31].
However, Hamed et al. reported significant association
between the two in diabetic patients [32]. In our study,
the mean and maximum values of right and overall
CIMT were significantly increased in H. pylori positive
subjects compared with negative subjects. The mean and
maximum values of left CIMT tended to be higher in
H. pylori infected subjects but the differences were not
significant between the two groups. We determined the
correlations between PON1, HDL-C and CIMT respec-
tively. While CIMT was negatively correlated to HDL-C,
it showed no correlation with PON1. As is reported by
Chen et al., HDL-C is a complex particle populated by
multiple proteins that play a critical role in determining
the overall effects of the lipoprotein [33]. Our results
demonstrate that, PON 1 singularly could not represent
the overall antioxidative activity of HDL-C.
The current study has certain limitations. Our study
group was limited. We did not perform endoscopy and
determine the grade of gastric inflammation or virulence
factors of H. pylori.
In conclusion; serum PON1 activities were lower in
H. pylori positive subjects while right and overall CIMT
were significantly higher. Although we found no correla-
tion between CIMT and PON1, these results implied
that decreased PON1 activity may have an important
role on vascular structural changes induced by H. pylori
infection. Further studies with larger populations are
needed to explore whether there is a strong relationship
between PON1 activity and atherosclerosis in H. pylori
infection.
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